TrialJournal of hematology & oncology2016

PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

Jingshi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.